2023
DOI: 10.1523/eneuro.0449-22.2023
|View full text |Cite
|
Sign up to set email alerts
|

β2 nAChR Activation on VTA DA Neurons Is Sufficient for Nicotine Reinforcement in Rats

Abstract: Mesolimbic nicotinic acetylcholine receptor (nAChRs) activation isnecessaryfor nicotine reinforcement behavior, but it is unknown whether selective activation of nAChRs in the dopamine (DA) reward pathway issufficientto support nicotine reinforcement. In this study, we tested the hypothesis that activation of β2-containing (β2*) nAChRs on VTA neurons is sufficient for intravenous nicotine self-administration (SA). We expressed β2 nAChR subunits with enhanced sensitivity to nicotine (referred to as β2Leu9′Ser) … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 56 publications
0
1
0
Order By: Relevance
“…The dogma is that any drug or behavior that increases mesolimbic DA neuron activity and release will be reinforcing, and potentially addictive, and that withdrawal from chronic drug abuse results in dysregulation of DA transmission. This reduction in mesolimbic DA transmission is theorized to be the primary driver of relapse . Furthermore, nicotinic acetylcholine receptors (nAChRs) expressed in both the VTA and the NAcc have been implicated in the reward pathway and are a potential therapeutic target for various substance use disorders. …”
Section: Introductionmentioning
confidence: 99%
“…The dogma is that any drug or behavior that increases mesolimbic DA neuron activity and release will be reinforcing, and potentially addictive, and that withdrawal from chronic drug abuse results in dysregulation of DA transmission. This reduction in mesolimbic DA transmission is theorized to be the primary driver of relapse . Furthermore, nicotinic acetylcholine receptors (nAChRs) expressed in both the VTA and the NAcc have been implicated in the reward pathway and are a potential therapeutic target for various substance use disorders. …”
Section: Introductionmentioning
confidence: 99%